Ron Cohen
Overview
Ron Cohen received an average of $3M in total compensation, including $660K in salary, at Acorda Therapeutics from 2006 to 2022.
2022Acorda TherapeuticsPresident and Chief Executive Officer
2021Acorda TherapeuticsPresident and Chief Executive Officer
2020Acorda TherapeuticsPresident and Chief Executive Officer
2019Acorda TherapeuticsPresident and Chief Executive Officer
2018Acorda TherapeuticsPresident and Chief Executive Officer
2017Acorda TherapeuticsPresident and Chief Executive Officer
2016Acorda TherapeuticsPresident and Chief Executive Officer
2015Acorda TherapeuticsPresident and Chief Executive Officer
2014Acorda TherapeuticsPresident and Chief Executive Officer
2013Acorda TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 27, 2023, April 28, 2022, April 23, 2021, April 28, 2020, April 26, 2019, April 27, 2018, April 21, 2017, April 29, 2016, April 30, 2015, April 25, 2014, April 19, 2013, April 26, 2012, April 29, 2011, April 27, 2010, and April 30, 2009.
Related executives
We found 12 more executives who work or worked at Acorda Therapeutics.
Kerry Clem
Acorda Therapeutics
Chief Commercial Officer
Lauren Sabella
Acorda Therapeutics
Chief Operating Officer
Michael Gesser
Acorda Therapeutics
Chief Finance Officer and Treasurer
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
David Lawrence
Acorda Therapeutics
Former Chief, Business Operations and Principal Accounting Officer
Jane Wasman
Acorda Therapeutics
General Counsel
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019